Filing Details
- Accession Number:
- 0001061983-17-000056
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-08 16:48:02
- Reporting Period:
- 2017-09-06
- Accepted Time:
- 2017-09-08 16:48:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1061983 | Cytokinetics Inc | CYTK | Pharmaceutical Preparations (2834) | 943291317 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1674232 | Gordon Caryn Mcdowell | 280 East Grand Avenue South San Francisco CA 94080 | Gc & Chief Compliance Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-09-06 | 1,432 | $6.67 | 19,801 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-09-06 | 200 | $14.10 | 19,601 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-09-06 | 3,067 | $6.67 | 22,668 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-09-06 | 200 | $14.15 | 22,468 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-09-06 | 5,732 | $6.37 | 28,200 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-09-06 | 898 | $14.20 | 27,302 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 400 | $14.25 | 26,902 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 100 | $14.28 | 26,802 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 302 | $14.30 | 26,500 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 200 | $14.35 | 26,300 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 200 | $14.38 | 26,100 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 400 | $14.40 | 25,700 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 600 | $14.45 | 25,100 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 200 | $14.48 | 24,900 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 200 | $14.50 | 24,700 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 200 | $14.53 | 24,500 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 200 | $14.58 | 24,300 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 700 | $14.60 | 23,600 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 300 | $14.63 | 23,300 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 200 | $14.65 | 23,100 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 500 | $14.70 | 22,600 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 200 | $14.73 | 22,400 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 600 | $14.75 | 21,800 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 400 | $14.78 | 21,400 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 400 | $14.80 | 21,000 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 100 | $14.83 | 20,900 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 724 | $14.85 | 20,176 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 600 | $14.90 | 19,576 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 400 | $14.93 | 19,176 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-09-06 | 707 | $14.95 | 18,469 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2017.